Sumita Ray
CIK 1579629 · Chief Legal Compliance Officer · last filed 2026-07-10
Sumita Ray is a Chief Legal Compliance Officer who has filed 22 SEC Form 4 insider transactions across 5 companies since 2017. The most recent filing, for CUE, was dated Jul 10, 2026. Current disclosed insider exposure totals $3.3M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.30M
5
22
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CUE | Chief Legal Compliance Officer | 109,178 | $30.25 | $3.30M | $0 | 1 | 2026-07-10 |
| BMEA | Director | — | $1.25 | — | $0 | 7 | 2026-06-12 |
| Vaxxinity, Inc. (VAXX) Delisted | Chief Legal, Comp & Admin Off | — | $0.11 | — | $0 | 1 | 2024-04-29 |
| TIL | Chief Legal and Admin Officer | — | $7.29 | — | $0 | 1 | 2023-01-20 |
| Calithera Biosciences, Inc. (CALA) Delisted | See Remarks | 5,250 | $0.00 | $2 | $0 | 8 | 2022-01-27 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-10 | CUE | Grant (A) | +54,589 | $0 | EDGAR |
| 2026-06-12 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2025-06-13 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2024-06-13 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2024-04-29 | Vaxxinity, Inc. (VAXX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-16 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2023-01-20 | TIL | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2022-03-07 | BMEA | Grant (A) | — | $0 | EDGAR |
| 2022-01-27 | Calithera Biosciences, Inc. (CALA) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.